小剂量化疗TACE术治疗原发性肝癌

来源 :第十届中国介入放射学学术大会(CSIR2012)暨2012国际栓塞会议(GEST2012) | 被引量 : 0次 | 上传用户：tezon1

【摘要】

：

目的:对照分析小剂量和常规剂量化疗药物经动脉化疗栓塞术(TACE)对原发性肝癌(HCC)患者肝纤维化和生存期的影响.方法:对60例HCC患者行TACE,其中A组(n=30)给予小剂量化疗药物,B组(n=30)给予常规剂量化疗药物.分别检测TACE术前、术后7d患者血清透明质酸(HA)人Ⅲ型前胶原(hPC-Ⅲ)、层粘蛋白(LN)Ⅳ型前胶原(Ⅳ-C),同时比较两组中位生存期.

【作者】

：

孔伟东曹建民许健许潭潭杨涛陈波韩宗宏

【机构】

：

南京军区南京总医院医学影像科

【出处】

：

第十届中国介入放射学学术大会(CSIR2012)暨2012国际栓塞会议(GEST2012)

【发表日期】

：

2012年11期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Neoadjuvant Chemotherapy Has Better Compliance than Adjuvant Chemotherapy in Locally Advanced Gastri

Objective: Neoadjuvant chemotherapy draws more attention these years due to many theoretical advantages, of which better compliance is one, however, it hasnt been fully proved.We aimed to compare the

会议

Postoperative Intravenous Chemotherapy Combined with Intraperitoneal Perfusion Chemotherapy versus I

Objective: Gastric cancer is a common cancer with relatively poor survival rates.Gastric resection and intravenous chemotherapy are the current accepted standard treatment.Intraperitoneal chemotherapy

会议

Effect of Reconstruction Methods and Other Risk Factors on Postoperative Complications of Total Gast

Objective: Gastric cancer is one of the most common malignant tumors in China and radical gastrectomy remains the only way to cure it.Total gastrectomy, as a frequently used operation in gastric cance

会议

Efficacy and safety of regorafenib (REG) monotherapy in Chinese patients with previously treated met

Objective: The new oral multi-kinase inhibitor REG improves overall survival (OS) in mCRC patients who progress after standard therapies.CONCUR (NCT01584830) evaluated the efficacy and safety of REG i

会议

Survival outcome of operated and non-operated young patients with colon cancer: A population based s

Objective: To compare the long-term survival of operated and non-operated colon cancer (CC) in young patients with elderly ones.Method: Using Surveillance, Epidemiology, and End Results (SEER) populat

会议

具有基底细胞样表型的三阴性乳腺癌的临床病理特征及预后分析

目的:本研究拟通过三阴性乳腺癌有关的免疫标记物的表达、临床表现及生物学行为等一系列研究,探讨具有基底细胞样表型的三阴性乳腺癌的临床病理特征及预后相关因素.方法:收集128例1999年1月-2006年12月术前未接受任何治疗、无第二原发肿瘤的ER、PR、HER2阴性乳腺癌患者的临床病理资料,追踪随访患者生存信息,复阅切片,择取有代表性的肿瘤组织,应用组织微阵列技术、免疫组化染色技术,检测ER、PR、

会议

Treatment patterns in >3000 sorafenib-treated patients: final analysis of GIDEON (Global Investig

Objective:To evaluate sorafenib (Sor) use in clinical practice in patients with hepatocellular carcinoma (HCC).Methods:GIDEON is a prospective, international, observational study.Patients with diagnos

会议

Randomized controlled trial of intraportal chemotherapy combined with adjuvant chemotherapy (mFOLFOX

Objective: The optimal time from surgery to the start of adjuvant chemotherapy in colon cancer is unknown.We evaluated the impact on survival of intraportal chemotherapy (IPC) administered during surg

会议

Intratumoral Heterogeneity Impacts Drug Sensitivity and the Provides Opportunity for Precise Persona

Objective: The diversity of cancer genome significantly influences drug response and impairs the discovery of biomarker for patient stratification.As important preclinical models, patient derived cell

会议

TACE of HCC Patients with Portal Vein Tumor Thrombosis : Survival Analysis Using a New Classificatio

Objective: To explore the efficacy of transarterial chemoembolization (TACE) for HCC patients with different portal vein tumor thrombosis (PVTT), to reveal which PVTT types could benefit from the trea

会议

小剂量化疗TACE术治疗原发性肝癌

其他学术论文